Advancing the Future of Cancer Treatment

We’re focused on developing innovative therapies that address some of the most challenging cancers. Our goal is to deliver safer, more durable treatment options that support patients throughout every stage of their cancer journey.

Our approach brings together cutting-edge research, modern drug development, and deep clinical expertise to advance meaningful progress in cancer care.

Our Pipeline

We’re developing first-in-class small molecules and peptide therapeutics to unlock a healthier metabolism safely and effectively.

Preclinical
Program

TMPRSS6

Indication

Polycythemia Vera

Est. Ph I Initiation

Q1 2026

Modality

siRNA

Join the Future of Inflammatory Disease Treatment

Vial’s clinical research teams are working with investigators across multiple specialties to evaluate the next wave of immunology therapeutics. Individuals with immune-mediated inflammatory conditions may be eligible for early studies.

Contact

Information

Join our mail list

"*" indicates required fields

Get in touch!

Compose the future with us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.